Leiden Preclinical Research Services (LPRS) provides tailor-made preclinical research services to pharmaceutical, biotechnology and medical device companies.

Our inspiring portfolio in disease areas such as cancer, cardiovascular diseases, diabetes and obesity includes among others: State-of-the-art technology platforms, Innovative screening methods in unique in vitro models and animal models, In-depth mechanistic in vitro and in vivo studies and Epidemiology to clinical (cohort) studies.